Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A grade I, slowly growing meningioma. Only a minority of tumors recur following complete resection.
Biomarker and diagnostic research for benign meningioma has been reported in the published literature.
61 clinical trials registered, 39 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and medical devices. Pipeline includes 2 PHASE4, 12 PHASE2, 8 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04081701](https://clinicaltrials.gov/study/NCT04081701) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:46 AM UTC
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. |
PHASE4 |
Weill Medical College of Cornell University |
RECRUITING |
[NCT06930846](https://clinicaltrials.gov/study/NCT06930846) | HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) | NA | Dartmouth-Hitchcock Medical Center | RECRUITING |
[NCT07428616](https://clinicaltrials.gov/study/NCT07428616) | A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma | PHASE2 | Exelixis | RECRUITING |
[NCT05940493](https://clinicaltrials.gov/study/NCT05940493) | Abemaciclib in Newly Diagnosed Meningioma Patients | PHASE2 | Nader Sanai | RECRUITING |
[NCT06036706](https://clinicaltrials.gov/study/NCT06036706) | Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: | NA | Centre Francois Baclesse | RECRUITING |
98 publications have been identified in PubMed for benign meningioma. Research spans Case Report / Case Series (29%), Basic Science / Preclinical (21%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 28 | 29% |
Laboratory research | 21 | 21% |
Research summaries | 18 | 18% |
Disease patterns and progression | 11 | 11% |
Testing and diagnosis research | 8 | 8% |
Clinical study results | 8 | 8% |
New treatment approaches | 4 | 4% |
Shi P (2026). [PMID: 41612813](https://pubmed.ncbi.nlm.nih.gov/41612813/). *Brain Behav*. [Epidemiology / Natural History]
Gao W (2026). [PMID: 41225268](https://pubmed.ncbi.nlm.nih.gov/41225268/). *Eur Spine J*. [Gene Therapy / Novel Therapeutics]
Pandey VK (2026). [PMID: 41804397](https://pubmed.ncbi.nlm.nih.gov/41804397/). *Cureus*. [Case Report / Case Series]
Patel T (2026). [PMID: 42116895](https://pubmed.ncbi.nlm.nih.gov/42116895/). *Surg Neurol Int*. [Epidemiology / Natural History]
Keiser DJ (2026). [PMID: 41929148](https://pubmed.ncbi.nlm.nih.gov/41929148/). *bioRxiv*. [Basic Science / Preclinical]
Sulman M (2026). [PMID: 42107879](https://pubmed.ncbi.nlm.nih.gov/42107879/). *World Neurosurg*. [Basic Science / Preclinical]
Romeo MA (2026). [PMID: 42272750](https://pubmed.ncbi.nlm.nih.gov/42272750/). *Clin Ophthalmol*. [Diagnostic / Biomarker]
Kumar P (2026). [PMID: 41608250](https://pubmed.ncbi.nlm.nih.gov/41608250/). *Cureus*. [Epidemiology / Natural History]
Mahtab P (2026). [PMID: 41914105](https://pubmed.ncbi.nlm.nih.gov/41914105/). *Mymensingh Med J*. [Basic Science / Preclinical]
Vozel D (2026). [PMID: 41560283](https://pubmed.ncbi.nlm.nih.gov/41560283/). *Radiol Oncol*. [Epidemiology / Natural History]